A Mobile App Serious Game to Increase Awareness of Antibiotic Use in the Community
NCT05445414 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 480
Last updated 2023-10-18
Summary
The widespread and unnecessary use of antibiotics has encouraged the growth of antibiotic-resistant bacteria which can cause hard-to-treat and deadly infections. These infections are due to antimicrobial resistance (AMR). The public's lack of knowledge on the indication for and proper use of antibiotics often leads to unnecessary patient demands and subsequent misuse of antibiotics. Traditional mass public educational efforts through the use of brochures, posters and advertisements are extensive in outreach but questionable in effectiveness in improving the general public's knowledge on appropriate antibiotics use and AMR.
Serious games app provides an additional venue for public education outreach to the population since a substantial amount of time is spent using smartphones. The use of serious games is expected to increase user engagement in learning, which will lead to short- and long-term improvements in knowledge, attitudes and perceptions on the appropriate use of antibiotics.
The study team has co-developed an evidence-based serious game app- "SteWARdS Antibiotic Defense" -with Temasek Polytechnic. Users will be brought on a quest to learn about antibiotic use and AMR through mini-games and the bite-sized information released throughout the game quest. We intend to clinically validate our evidence-based app and improve its application with actual participants' feedback on its usage. Hence, this study aims to evaluate the effectiveness of an evidence-based serious game mobile application (SteWARdS Antibiotic Defense) in improving the knowledge on, attitude towards, and perception (KAP) of appropriate antibiotic use and AMR among Singaporeans.
The primary objective is to assess the change in knowledge on antibiotic use and AMR among the app users compared with the control group. The secondary objectives are to:1) Assess the extent of user engagement of the app by evaluating the users' average screen time per day; and 2) Assess the level of user satisfaction in using the app for learning through a user satisfaction survey.
Conditions
Interventions
- DEVICE
-
"SteWARdS Antibiotic Defense" app
The "SteWARdS Antibiotic Defense" app is an evidence-based serious game app developed by the study team. The app uses gamification theories to increase user engagement and to deliver bite-sized information to participants. For example, players will learn about the uses of antibiotics through the messages delivered through the game and the cost of tackling antibiotic-resistant infections through purchasing an expensive antibiotic with the virtual currency earned from the games.
Sponsors & Collaborators
-
National Healthcare Group Polyclinics
collaborator OTHER_GOV -
Temasek Polytechnic
collaborator UNKNOWN -
Tan Tock Seng Hospital
lead OTHER
Principal Investigators
-
Zhilian Huang, Ph.D · Tan Tock Seng Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-01-04
- Primary Completion
- 2023-05-29
- Completion
- 2023-08-31
Countries
- Singapore
Study Locations
More Related Trials
-
Whole Blood Bactericidal Activity Against Mycobacterium Tuberculosis of Pyrazinamide Plus Allopurinol in Healthy Volunteers
NCT02700347 ·Status: COMPLETED ·Phase: PHASE1
-
STaph Aureus Resistance-Treat Early and Repeat (STAR-TER)
NCT03489629 ·Status: COMPLETED ·Phase: PHASE2
-
Challenge of the Nasopharynx With Neisseria Lactamica Expressing the Meningococcal Protein Neisseria Adhesin A (NadA)
NCT03630250 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Effectiveness of Antibiotic Delivery Via Bio-absorbable Sponge
NCT01222832 ·Status: COMPLETED ·Phase: PHASE2
-
The BLAST- 1 Trial - Cephalexin+Amoxicillin-clavulanate for Tuberculosis
NCT05664568 ·Status: UNKNOWN ·Phase: PHASE2
-
A Prospective Registry For Non Tuberculous Mycobacterial (NTM) Infections
NCT02355015 ·Status: UNKNOWN
-
Study Evaluating Safety, Tolerability, and Efficacy of Intravenous AP-SA02 in Subjects With S. Aureus Bacteremia
NCT05184764 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Clinical Study on the Treatment of Lower Respiratory Tract Infection With Pseudomonas Aeruginosa by Ceftazidime and Avibatam
NCT06992102 ·Status: COMPLETED
-
Effective Antimicrobial StewaRdship StrategIES (ARIES)
NCT04011657 ·Status: COMPLETED ·Phase: NA
-
BrighT STAR LIBRA: Leveraging Implementation Science for Blood Culture Reduction Approaches
NCT06187662 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Pilot Trial of Inhaled Molgramostim in Non-tuberculous Mycobacterial (NTM) Infection
NCT03421743 ·Status: COMPLETED ·Phase: PHASE2
-
Study Evaluating Local Susceptibility Patterns Associated With Tigecycline in Comparison to Other Antibiotics
NCT01311349 ·Status: COMPLETED
-
Effects of an Antimicrobial Stewardship (AMS) Program, on the Prevalence of Multidrug-resistant Gram - Negative Pathogens, in an Area of High Consumption of Antibiotics and High Resistance Rates
NCT04261348 ·Status: UNKNOWN
-
Methicillin-resistant Staphylococcus Aureus (MRSA) Skin and Soft Tissue Infection (SSTI) Prevention in Military Trainees
NCT01105767 ·Status: COMPLETED ·Phase: NA
-
Effectiveness and Safety of Tigecycline for Therapy of Infections Caused by Multi-Drug Resistant Acinetobacter Baumannii
NCT01342731 ·Status: UNKNOWN ·Phase: PHASE4
-
A Trial to Evaluate the Loading Dose Required to Achieve Therapeutic Serum Teicoplanin Concentration Timely
NCT00368498 ·Status: UNKNOWN ·Phase: PHASE4
-
Antibiotics Use and Carriage of Methicillin-resistant Staphylococci in Community Patients
NCT01489878 ·Status: COMPLETED
-
NAsal MEthicillin-resistant Staphylococcus (NAMES): a Prospective Study to Assess the Impact of Antibiotic Therapy on Nasal Colonization with Methicillin-resistant Staphylococcus Aureus (MRSA) Inhospitalized Children
NCT06872099 ·Status: RECRUITING
-
Prospective Study Into the Performance of the MicroPhage S. Aureus/MSSA/MRSA Test Direct From Blood Culture Positives
NCT01184339 ·Status: COMPLETED
-
INSPIRE Trial for Skin and Soft Tissue Infections
NCT05423756 ·Status: COMPLETED ·Phase: NA
-
Study to Assess the Efficacy and Safety of STI-1558 in Adult Subjects With Mild or Moderate (COVID-19)
NCT05716425 ·Status: COMPLETED ·Phase: PHASE3
-
Strategies Using Off-Patent Antibiotics for Methicillin Resistant S. Aureus "STOP MRSA"
NCT00729937 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Collect Clinical Data in Chinese Patients Received CUBICIN Treatment for Actual Usage in Clinical Practice
NCT01212601 ·Status: COMPLETED
-
An Open-label RCT to Evaluate a New Treatment Regimen for Patients With Multi-drug Resistant Tuberculosis
NCT02454205 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Study to Investigate the Safety, Tolerability, and Pharmacokinetics of DSTA4637S in Participants With Staphylococcus Aureus Bacteremia Receiving Standard-of-Care (SOC) Antibiotics
NCT03162250 ·Status: COMPLETED ·Phase: PHASE1